154 related articles for article (PubMed ID: 35292415)
1. Synthesis and evaluation of sulfosuccinate-based surfactants as counterions for hydrophobic ion pairing.
Wibel R; Knoll P; Le-Vinh B; Kali G; Bernkop-Schnürch A
Acta Biomater; 2022 May; 144():54-66. PubMed ID: 35292415
[TBL] [Abstract][Full Text] [Related]
2. Oral delivery of calcitonin-ion pairs: In vivo proof of concept for a highly lipophilic counterion.
Wibel R; Jörgensen AM; Laffleur F; Spleis H; Claus V; Bernkop-Schnürch A
Int J Pharm; 2023 Jan; 631():122476. PubMed ID: 36528188
[TBL] [Abstract][Full Text] [Related]
3. Hydrophobic ion pairing of a GLP-1 analogue for incorporating into lipid nanocarriers designed for oral delivery.
Ismail R; Phan TNQ; Laffleur F; Csóka I; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2020 Jul; 152():10-17. PubMed ID: 32371152
[TBL] [Abstract][Full Text] [Related]
4. Counterion optimization for hydrophobic ion pairing (HIP): Unraveling the key factors.
Claus V; Sandmeier M; Hock N; Spleis H; Lindner S; Kalb M; Bernkop-Schnürch A
Int J Pharm; 2023 Nov; 647():123507. PubMed ID: 37848166
[TBL] [Abstract][Full Text] [Related]
5. Hydrophobic ion pairing: Key to highly payloaded self-emulsifying peptide drug delivery systems.
Griesser J; Hetényi G; Moser M; Demarne F; Jannin V; Bernkop-Schnürch A
Int J Pharm; 2017 Mar; 520(1-2):267-274. PubMed ID: 28188875
[TBL] [Abstract][Full Text] [Related]
6. Peptide release from SEDDS containing hydrophobic ion pair therapeutic peptides measured by Taylor dispersion analysis.
Chamieh J; Domènech Tarrat A; Doudou C; Jannin V; Demarne F; Cottet H
Int J Pharm; 2019 Mar; 559():228-234. PubMed ID: 30703502
[TBL] [Abstract][Full Text] [Related]
7. Chemistry and Geometry of Counterions Used in Hydrophobic Ion Pairing Control Internal Liquid Crystal Phase Behavior and Thereby Drug Release.
Ristroph K; Salim M; Clulow AJ; Boyd BJ; Prud'homme RK
Mol Pharm; 2021 Apr; 18(4):1666-1676. PubMed ID: 33656349
[TBL] [Abstract][Full Text] [Related]
8. A novel in situ hydrophobic ion paring (HIP) formulation strategy for clinical product selection of a nanoparticle drug delivery system.
Song YH; Shin E; Wang H; Nolan J; Low S; Parsons D; Zale S; Ashton S; Ashford M; Ali M; Thrasher D; Boylan N; Troiano G
J Control Release; 2016 May; 229():106-119. PubMed ID: 27001894
[TBL] [Abstract][Full Text] [Related]
9. Hydrophobic Ion Pairing of Small Molecules: How to Minimize Premature Drug Release from SEDDS and Reach the Absorption Membrane in Intact Form.
Spleis H; Federer C; Claus V; Sandmeier M; Bernkop-Schnürch A
ACS Biomater Sci Eng; 2023 Mar; 9(3):1450-1459. PubMed ID: 36786693
[TBL] [Abstract][Full Text] [Related]
10. Oral self-emulsifying delivery systems for systemic administration of therapeutic proteins: science fiction?
Phan TNQ; Le-Vinh B; Efiana NA; Bernkop-Schnürch A
J Drug Target; 2019 Nov; 27(9):1017-1024. PubMed ID: 30776924
[No Abstract] [Full Text] [Related]
11. Self-emulsifying drug delivery systems: A versatile approach to enhance the oral delivery of BCS class III drug via hydrophobic ion pairing.
Asad M; Rasul A; Abbas G; Shah MA; Nazir I
PLoS One; 2023; 18(6):e0286668. PubMed ID: 37294790
[TBL] [Abstract][Full Text] [Related]
12. Sulfosuccinate and Sulfocarballylate Surfactants As Charge Control Additives in Nonpolar Solvents.
Smith GN; Kemp R; Pegg JC; Rogers SE; Eastoe J
Langmuir; 2015 Dec; 31(51):13690-9. PubMed ID: 26609708
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Counterions in Hydrophobic Ion Pairs on Oral Bioavailability of Exenatide.
Phan TNQ; Ismail R; Le-Vinh B; Zaichik S; Laffleur F; Bernkop-Schnürch A
ACS Biomater Sci Eng; 2020 Sep; 6(9):5032-5039. PubMed ID: 33455296
[TBL] [Abstract][Full Text] [Related]
14. Surfactant-coated aluminum hydroxide for the rapid removal and biodegradation of hydrophobic organic pollutants in water.
Saitoh T; Yamaguchi M; Hiraide M
Water Res; 2011 Feb; 45(4):1879-89. PubMed ID: 21193213
[TBL] [Abstract][Full Text] [Related]
15. Impact of different hydrophobic ion pairs of octreotide on its oral bioavailability in pigs.
Bonengel S; Jelkmann M; Abdulkarim M; Gumbleton M; Reinstadler V; Oberacher H; Prüfert F; Bernkop-Schnürch A
J Control Release; 2018 Mar; 273():21-29. PubMed ID: 29355620
[TBL] [Abstract][Full Text] [Related]
16. Enabling superior drug loading in lipid-based formulations with lipophilic salts for a brick dust molecule: Exploration of lipophilic counterions and in vitro-in vivo evaluation.
Sirvi A; Jadhav K; Sangamwar AT
Int J Pharm; 2024 May; 656():124108. PubMed ID: 38604540
[TBL] [Abstract][Full Text] [Related]
17. Rationalizing Counterion Selection for the Development of Lipophilic Salts: A Case Study with Venetoclax.
Ryan CD; Griffin BT; O'Shea JP
Mol Pharm; 2024 Jun; 21(6):2981-2992. PubMed ID: 38703358
[TBL] [Abstract][Full Text] [Related]
18. Dissolution and partitioning behavior of hydrophobic ion-paired compounds.
Lengsfeld CS; Pitera D; Manning M; Randolph TW
Pharm Res; 2002 Oct; 19(10):1572-6. PubMed ID: 12425478
[TBL] [Abstract][Full Text] [Related]
19. Comparative Analysis of PEG-Free and PEG-Based Self-Emulsifying Drug Delivery Systems for Enhanced Oral Bioavailability of Therapeutic (Poly) Peptides.
Haddadzadegan S; To D; Matteo Jörgensen A; Wibel R; Laffleur F; Bernkop-Schnürch A
Small; 2024 Feb; ():e2307618. PubMed ID: 38308358
[TBL] [Abstract][Full Text] [Related]
20. API ionic liquids: probing the effect of counterion structure on physical form and lipid solubility.
Ford L; Tay E; Nguyen TH; Williams HD; Benameur H; Scammells PJ; Porter CJH
RSC Adv; 2020 Mar; 10(22):12788-12799. PubMed ID: 35492138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
